#health medical pharma

[nr1-logo-design-inspiration]

Branding your cosmetics business and developing a solid cosmetics strategy is a must if you want to succeed in today’s beauty market. First stage is logo design.

We are available for new logo & branding projects. Contact: [email protected]

#cosmetics #beauty products #skincare #skinclinic #pharmacy #health medical pharma #make up #beautiful women #eyeliner #flower illustration #tulips #monoline #luxury #logo #brand innovation #identity #visual storytelling #business #company #small biz

[elekid]

#low dose naltrexone #naltrexone #health medical pharma #big pharma #meds #medication #meme #system memes #system moodboard

[ionusapeiron]

#black and white #indie film #Syringe #pill #health medical pharma #drug #drug aesthetic

[blatantescapism]

does anybody know who we have to kill to fix the Ritalin supply issue

(the answer is NOT the pharmacists who are doing their absolute best)

#Ritalin #health medical pharma #supply chain issues

[emiliafonseca]

I think it's a pity how pharmaceutical companies control which illness is profitable to treat and which people shall die if they decide that a lifesaving pharmaceutical for some people is just not making them enough money and therefore no longer is sustainable to produce. I think it's a worldwide shame that health is treated like a good someone needs to profit from. We should start to think about the stuff we are able to do together as a whole, not on an individual level. We could do so much better if we'd wish to.

#health medical pharma #pharma industry #lobbying #health #healthcare #strange world #pharmaceutical #corporate greed #what do you think?

[viscountmelbourne]

“[The paper] doesn’t undermine the efficacy of antidepressants for those people for whom they work,” says Comaty. “But we just don’t know the biochemical theory of depression.” Such ambiguity may be unwelcome to those looking for definitive answers one way or the other about SSRIs. Uncertainty is an inevitable aspect of the scientific process, Comaty says, and one that should be welcomed rather than cited as evidence of psychiatric medication’s uselessness, as some on the right have done.

#science #scientists #medicine #antidepressants #health medical pharma #clinical depression

[pharmaceitucal]

#big pharma #health medical pharma #medicine

[reasonsforhope]

"The Biden Administration last week [early December, 2023] announced it would be seizing patents for drugs and drug manufacturing procedures developed using government money.

A draft of the new law, seen by Reuters, said that the government will consider various factors including whether a medical situation is leading to increased prices of the drug at any given time, or whether only a small section of Americans can afford it.

The new executive order is the first exercise in what is called “march-in-rights” which allows relevant government agencies to redistribute patents if they were generated under government funding. The NIH has long maintained march-in-rights, but previous directors have been unwilling to use them, fearing consequences.

“We’ll make it clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House adviser Lael Brainard said on a press call.

But just how much taxpayer money is going toward funding drugs? A research paper from the Insitute for New Economic Thought showed that “NIH funding contributed to research associated with every new drug approved from 2010-2019, totaling $230 billion.”

The authors of the paper continue, writing “NIH funding also produced 22 thousand patents, which provided marketing exclusivity for 27 (8.6%) of the drugs approved [between] 2010-2019.”

How we do drug discovery and production in America has a number of fundamental flaws that have created problems in the health service industry.

It costs billions of dollars and sometimes as many as 5 to 10 years to bring a drug to market in the US, which means that only companies with massive financial muscle can do so with any regularity, and that smaller, more innovative companies can’t compete with these pharma giants.

This also means that if a company can’t recoup that loss, a single failed drug can result in massive disruptions to business. To protect themselves, pharmaceutical companies establish piles of patents on drugs and drug manufacturing procedures. Especially if the drug in question treats a rare or obscure disease, these patents essentially ensure the company has monoselective pricing regimes.

However, if a company can convince the NIH that a particular drug should be considered a public health priority, they can be almost entirely funded by the government, as the research paper showed.

Some market participants, in this case the famous billionaire investor Mark Cuban, have attempted to remedy the issue of drug costs in America by manufacturing generic versions of patented drugs sold for common diseases."

-via Good News Network, December 11, 2023

#united states #us politics #biden administration #executive order #prescription drugs #medical news #healthcare #healthcare access #biden #big pharma #drug prices #public health #nih #national institutes of health #good news #hope

[peak-of-mountain]

#health medical pharma

[mtm4u]

#health medical pharma

[thecomptonplace]

Delta 8 Peach Gummies - Compton Place Farms

Indulge in the delightful combination of sweet, juicy peaches and the therapeutic effects of Delta 8 with our Delta 8 Peach Gummies. These gummies are expertly crafted to provide a delicious and convenient way to experience the potential benefits of Delta 8. Each gummy contains a precise dosage, ensuring consistency and control over your experience. Whether you're seeking relaxation, relief, or simply a tasty treat, our Delta 8 Peach Gummies are a perfect choice.

#health medical pharma #herbal

[nr1-logo-design-inspiration]

Logo design for a medical business ☆☆☆

Need a logo? PM us!

[email protected]

#health medical pharma #pharmacy #medicare #medicine #logo #business #entrepreneur #illustration #branding #artists on tumblr #creative #startup #pigeon #birds #mockup #packaging #pattern

[rklifecare1]

A pharmaceutical company company in india

Pharmaceutical companies operate in a highly regulated environment due to the critical nature of their products. They need to adhere to strict regulations and guidelines set by regulatory authorities to ensure patient safety and product quality. These regulations cover areas such as clinical trials, manufacturing practices, labeling, and advertising.

visit us: https://www.rklifecare.com/

#pharma manufacturing #health medical pharma #big pharma #rklifecare

[theshapeofcool]

Watch "Barely Contained Rage: An Open Letter to Johnson & Johnson" on YouTube

#johnson and johnson #vlogbrothers #bedaquiline #tuberculosis #TB #health medical pharma #pharmaceutical companies putting profits over people #i am shocked #but like #not really #Youtube

[thepharmtalesusa]

Pfizer's Talzenna Gains FDA Approval for Prostate Cancer, Aiming to Compete with Lynparza

Pfizer, a leading pharmaceutical company, has received FDA approval for its PARP inhibitor, Talzenna (talazoparib), in the treatment of castration-resistant prostate cancer (CRPC).

This approval positions Pfizer to compete with Lynparza, the market leader jointly developed by AstraZeneca and Merck & Co. By combining Talzenna with its well-known hormonal medication, Xtandi (enzalutamide), Pfizer aims to provide a first-line treatment option for patients with metastatic homologous recombination repair (HRR) gene-mutated CRPC.

The premier source for the Latest news in the pharmaceutical industry, Pharmtales is the Leading company in USA, they provide Latest News in Pharmacy in their blogs. This topic is also covered by the Pharmtales.

They provide comprehensive coverage of all topics like drug therapies, liver problems, regulatory changes and etc. They with their expertise and dedication, bring you up-to-date information, breakthrough advancements, and in-depth insights into the dynamic world of pharmacy.

The approval of Talzenna marks a significant milestone for Pfizer in expanding its presence in the prostate cancer treatment landscape.

TALAPRO-2 Study Results and Implications

The FDA's approval of Talzenna for CRPC is supported by the TALAPRO-2 study, which compared Talzenna to a placebo when added to Xtandi. The study demonstrated promising results, showing a 37% increase in radiographic progression-free survival (rPFS) and a 55% decrease in the probability of disease progression or death in the PARP inhibitor group. These findings indicate the potential of Talzenna as an effective treatment option for patients with HRR gene-mutated CRPC.

Market Competition and Revenue Potential

Pfizer's entry into the PARP inhibitor market for prostate cancer treatment is expected to create competition for Lynparza. While Lynparza has been approved for various cancers, including ovarian, breast, prostate, and pancreatic cancers, Talzenna's approval is currently limited to BRCA-mutated, HER2-negative metastatic breast cancer.

However, Pfizer anticipates that the new indication for Talzenna in combination with Xtandi will enable it to generate significant yearly revenues, potentially reaching $1 billion. Although Lynparza generated approximately $4 billion in revenue last year, Pfizer's focus on the specific population of patients with HRR gene-mutated CRPC presents a promising opportunity for market growth.

Advancements in Prostate Cancer Treatment

The prostate cancer treatment landscape has witnessed significant advancements in recent years. Lynparza, in combination with Johnson & Johnson's hormonal therapy Zytiga, has shown positive results in the treatment of metastatic CRPC, leading to its outperformance in the market.

Additionally, J&J's own PARP inhibitor, niraparib, combined with abiraterone acetate, has recently received EU clearance for use in metastatic CRPC patients with BRCA mutations. These developments highlight the ongoing efforts to explore innovative treatment approaches for prostate cancer.

Future Prospects and Ongoing Research

Pfizer's commitment to prostate cancer treatment innovation is evident through its ongoing clinical trial, TALAPRO-3, which is expected to conclude next year. The trial evaluates the efficacy and safety of combining Talzenna and Xtandi for the treatment of metastatic castration-sensitive prostate cancer (CSPC) in patients with HRR deficiency. The results of the TALAPRO-3 trial will provide valuable insights into the effectiveness and potential benefits of this combination therapy in the targeted patient population. Pfizer's acquisition of Medivation, which brought Talzenna and Xtandi into its portfolio in 2016, has strengthened its position in the development of advanced treatment options for prostate cancer.

Stay up-to-date with the Latest News in Pharma by keeping yourself informed about the most recent research, breakthroughs, and innovations in the pharmaceutical industry.

Explore reputable online platforms that provide comprehensive coverage of the latest trends, advancements in drug therapies, liver problems, regulatory changes, and emerging technologies. Among these sources, Pharmtales.com stands out as the leading platform in the pharmaceutical news industry.

They cover a wide range of topics related to the pharma industry in their news and articles. Don't miss out on the wealth of information available through these sources to stay current with the Latest News in Pharma.

Conclusion

Pfizer's FDA approval of Talzenna for castration-resistant prostate cancer marks an important milestone in its efforts to compete with Lynparza, the current market leader in the PARP inhibitor class. The combination of Talzenna and Xtandi as a first-line treatment option for patients with HRR gene-mutated CRPC presents a promising opportunity for Pfizer to gain market share.

Ongoing clinical trials, such as TALAPRO-3, reflect Pfizer's dedication to exploring innovative treatment approaches for prostate cancer. As the prostate cancer treatment landscape continues to evolve, patients can look forward to improved outcomes and increased treatment options.

#pcd pharma products #pharma #pharma industry #pharmacy #pharma manufacturing #u.s. news #health medical pharma

[thirdpartypharmamanufacturing]

What is a Pharma Franchise? How does Pharma Franchise Business work

A pharma franchise is a business model where a pharmaceutical manufacturing company offers exclusive marketing and selling rights to a business owner. This business model offers convenience and liberty to the franchisee in terms of business, product procurement, order quantity, investment, and marketing!

Learn how PCD pharma franchise works:

The PCD company offers products with a set of protocols to follow or can give a monopoly to the franchisee. Both parties agree on the terms and then proceed with a business plan.

These rights are then chosen and negotiated if necessary regarding selling, marketing, distributing, and promoting pharmaceutical products. The pharma franchise company will communicate with the franchisee regarding these rights and agree on common terms.

The franchise owner will run promotional activities either in collaboration with the company or alone. These activities include all the trending factors of marketing medicines. He will also authorize channeling and distribution of products in a target market.

All such activities will be conducted following the morals and goodwill of the pharma company. The franchise owner will have to follow the ethical protocols of the company and the industry for doing fair business!

How to choose a pharma franchise company?

Consider checking the GMP and standard certifications of the PCD pharma franchise company and start looking into the products manufactured. You will need a business plan to follow and seek respective products from the top service providers.

Look into the franchise protocols and agreement terms beforehand and get them analyzed by a lawyer to gain more convenience. Learn what other services you can get when choosing a particular company based on their products!

This is how you can proceed with a pharma franchise business plan and establish your enterprise. Follow how this company works and become a part of this industry!

Also READ

#pcd pharma #pcd pharma franchise #pcd franchise #third party pharma manufacturing #pcd pharma business #pharma franchise #derma franchise #pcd pharma company #pcd pharma franchis #pcd #pharma franchise in india #pharmacy #health medical pharma #pharma industry #pharma pcd company #pharma franchise company #pharma franchise in andhra pradesh #pharma franchise products #pharma franchise business